242 related articles for article (PubMed ID: 25456746)
41. [Detection of executive function disorders with a standard neurodevelopmental follow-up of premature children].
Monnier M; Jaunin L; Bickle Graz M; Borradori Tolsa C; Hüppi P; Sancho Rossignol A; Barisnikov K; Forcada Guex M
Arch Pediatr; 2014 Sep; 21(9):944-52. PubMed ID: 25104578
[TBL] [Abstract][Full Text] [Related]
42. [Deficiency of the fatty-acid oxidising enzyme medium-chain acyl-CoA dehydrogenase (MCAD) in an adult, detected during a neonatal screening programme].
Derks TG; Jakobs H; Gerding A; Niezen-Koning KE; Reijngoud DJ; Smit GP
Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2185-90. PubMed ID: 15559414
[TBL] [Abstract][Full Text] [Related]
43. Rhabdomyolysis caused by an inherited metabolic disease: very long-chain acyl-CoA dehydrogenase deficiency.
Voermans NC; van Engelen BG; Kluijtmans LA; Stikkelbroeck NM; Hermus AR
Am J Med; 2006 Feb; 119(2):176-9. PubMed ID: 16443431
[No Abstract] [Full Text] [Related]
44. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels.
Stanley CA; Hale DE; Coates PM; Hall CL; Corkey BE; Yang W; Kelley RI; Gonzales EL; Williamson JR; Baker L
Pediatr Res; 1983 Nov; 17(11):877-84. PubMed ID: 6646897
[TBL] [Abstract][Full Text] [Related]
45. Neonatal ventricular tachyarrhythmias in medium chain acyl-CoA dehydrogenase deficiency.
Yusuf K; Jirapradittha J; Amin HJ; Yu W; Hasan SU
Neonatology; 2010; 98(3):260-4. PubMed ID: 20414003
[TBL] [Abstract][Full Text] [Related]
46. Screening of the most common medium-chain acyl CoA dehydrogenase (MCAD) deficiency mutation (K329E) in the Czech newborn population.
Kozàk L; Hrabincovà E; Rudolfoà J; Vràbelovà S; Freiberger T
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():49-50. PubMed ID: 11400780
[TBL] [Abstract][Full Text] [Related]
47. Reye syndrome and reye-like syndrome.
Gosalakkal JA; Kamoji V
Pediatr Neurol; 2008 Sep; 39(3):198-200. PubMed ID: 18725066
[TBL] [Abstract][Full Text] [Related]
48. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
[TBL] [Abstract][Full Text] [Related]
49. Intermittent rhabdomyolysis with adult onset associated with a mutation in the ACADVL gene.
Antunes AP; Nogueira C; Rocha H; Vilarinho L; Evangelista T
J Clin Neuromuscul Dis; 2013 Dec; 15(2):69-72. PubMed ID: 24263034
[TBL] [Abstract][Full Text] [Related]
50. Outcome in six patients with mitochondrial trifunctional protein disorders identified by newborn screening.
Sperk A; Mueller M; Spiekerkoetter U
Mol Genet Metab; 2010; 101(2-3):205-7. PubMed ID: 20659813
[TBL] [Abstract][Full Text] [Related]
51. Follow-up of patients with short-chain acyl-CoA dehydrogenase and isobutyryl-CoA dehydrogenase deficiencies identified through newborn screening: one center's experience.
Pena L; Angle B; Burton B; Charrow J
Genet Med; 2012 Mar; 14(3):342-7. PubMed ID: 22241096
[TBL] [Abstract][Full Text] [Related]
52. Positive newborn screen in a normal infant of a mother with asymptomatic very long-chain Acyl-CoA dehydrogenase deficiency.
McGoey RR; Marble M
J Pediatr; 2011 Jun; 158(6):1031-2. PubMed ID: 21429517
[TBL] [Abstract][Full Text] [Related]
53. VLCAD deficiency: pitfalls in newborn screening and confirmation of diagnosis by mutation analysis.
Boneh A; Andresen BS; Gregersen N; Ibrahim M; Tzanakos N; Peters H; Yaplito-Lee J; Pitt JJ
Mol Genet Metab; 2006 Jun; 88(2):166-70. PubMed ID: 16488171
[TBL] [Abstract][Full Text] [Related]
54. Sweet and sour aspects of medium-chain acyl CoA dehydrogenase deficiency. Commentary on K. Yusuf et al.: Neonatal ventricular tachyarrhythmias in medium chain acyl-CoA dehydrogenase deficiency (Neonatology 2010;98:260-264).
Derks TG
Neonatology; 2010; 98(3):265-7. PubMed ID: 20414004
[No Abstract] [Full Text] [Related]
55. Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis.
Wilson CJ; Champion MP; Collins JE; Clayton PT; Leonard JV
Arch Dis Child; 1999 May; 80(5):459-62. PubMed ID: 10208954
[TBL] [Abstract][Full Text] [Related]
56. Cardiomyopathy and pericardial effusion in infancy point to a fatty acid b-oxidation defect after exclusion of an underlying infection.
Spiekerkoetter U; Tenenbaum T; Heusch A; Wendel U
Pediatr Cardiol; 2003; 24(3):295-7. PubMed ID: 12457256
[TBL] [Abstract][Full Text] [Related]
57. Genotype-phenotype correlations: sudden death in an infant with very-long-chain acyl-CoA dehydrogenase deficiency.
Coughlin CR; Ficicioglu C
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S129-31. PubMed ID: 20107901
[TBL] [Abstract][Full Text] [Related]
58. Tandem mass spectrometry screening for very long-chain acyl-CoA dehydrogenase deficiency: the value of second-tier enzyme testing.
Spiekerkoetter U; Haussmann U; Mueller M; ter Veld F; Stehn M; Santer R; Lukacs Z
J Pediatr; 2010 Oct; 157(4):668-73. PubMed ID: 20547398
[TBL] [Abstract][Full Text] [Related]
59. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) in the UK.
Goddard P
J Fam Health Care; 2004; 14(4):90-2. PubMed ID: 15453442
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of neuromotor deficits in children with autism and children with a specific speech and language disorder.
Noterdaeme M; Mildenberger K; Minow F; Amorosa H
Eur Child Adolesc Psychiatry; 2002 Oct; 11(5):219-25. PubMed ID: 12469239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
